ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Inflammation"

  • 2016 American Transplant Congress

    Multiplex Profiling of Plasma Proteins After Xenogenic Lung Exposure.

    A. Azimzadeh,1 N. Cheng,1 X. Cheng,1 E. Schwartz,1 L. Burdorf,1 S. Dahi,1 N. Kubicki,1 D. Parsell,1 T. Zhang,1 D. Cooper,2 C. Phelps,3 D. Ayares,3 R. Pierson III.1

    1Univ. Of Maryland, Baltimore, MD; 2University of Pittsburgh, Pittsburgh, PN; 3Revivicor, Blacksburg, VA.

    Background: Porcine lungs exhibit injury by human blood and are only partially protected in GalTKO organs with additional human membrane cofactor protein (hCD46). Residual injury…
  • 2016 American Transplant Congress

    Inflammatory Conditions Switch the Effect of MSC on B Cells from Pro-Tolerogenic to Anti-Proliferative.

    M. Franquesa,1,2 F. Luk,1 S. Korevaar,1 L. Boon,3 F. Borras,2 M. Betjes,1 C. Baan,1 M. Hoogduijn.1

    1Transplantation and Nephrology Lab, Internal Medicine, Erasmus MC, Rotterdam, Netherlands; 2IVECAT, Nephrology Department, IGTP, Badalona, Spain; 3Bioceros, Utrecht, Netherlands.

    The immunomodulatory capacity of mesenchymal stem cells (MSC) makes them a promising therapeutic tool in transplantation. MSC are recently gaining interest for their immunomodulatory effects…
  • 2016 American Transplant Congress

    Microfluidics to Characterize Leukocyte Trafficking into Allografts and the Resolution of Inflammation.

    L. Boneschansker,1,2 D. Irimia,2 D. Briscoe.1

    1Transplant Research Program, Boston Children's Hospital, Boston; 2MGH, Boston.

    Pro-resolution mediators such as resolvins and axonal guidance receptor-ligand interactions are increasingly recognized to regulate leukocyte trafficking into sites of inflammation. The implication of this…
  • 2016 American Transplant Congress

    The Immunologic Profile of Brain Death in Humans: A Whole-Body Analysis.

    D. Carpenter,1,2 N. Matsuoka,1 J. Thome,1,3 T. Granot,1,3 C. Gordon,1,3 B. Kumar,1,3 T. Senda,1,3 M. Miron,1,3 J. Weiner,2 A. Griesemer,1,2 D. Farber.1,2,3

    1Columbia Center for Translational Immunology, Columbia University Medical Center, New York City, NY; 2Surgery, Columbia University Medical Center, New York City, NY; 3Microbiology and Immunology, Columbia University Medical Center, New York City, NY.

    Transplantation outcomes are believed to be influenced by a generalized inflammatory state caused by brain death itself or events in the peri-transplant period. Studies on…
  • 2016 American Transplant Congress

    Optimizing the Immunogenicity and Immunomodulatory Properties of MSC for Cellular Therapy.

    S. de Witte,1 M. Franquesa,1 T. Strini,1 S. Korevaar,1 F. Luk,1 S. Elliman,2 P. Newsome,3 M. Gargesha,4 D. Roy,4 A. Merino,1 C. Baan,1 M. Hoogduijn.1

    1ErasmusMC, Rotterdam, Netherlands; 2Orbsen Therapeutics, Galway, Ireland; 3University of Birmingham, Birmingham, United Kingdom; 4Bioinvision, Mayfield Village.

    Mesenchymal stromal cells (MSC) are candidates for immunotherapy after transplantation. MSC have shown to be immunomodulatory and low immunogenic, which is favorable for cellular therapy…
  • 2016 American Transplant Congress

    Rapamycin Nanotherapy Delays Heart Transplant Rejection.

    M. Braza,1 M. Lameijer,1 C. Perez-Medina,1 T. Reiner,3 M. Nahrendorf,4 Z. Fayad,1 R. Duivenvoorden,1 J. Ochando,2 W. Mulder.1

    1Translational and Molecular Imaging Institute, Icahn School of Medicine at Mount Sinai, New York; 2Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York; 3Radiology, Memorial Sloan-Kettering Cancer Center, New York; 4Center for Systems Biology, Massachusetts General Hospital and Harvard Medical School, Boston.

    Background:In patients, allograft survival requires a cocktail of immunosuppressive drugs, while experimentally antibodies targeting the innate immune system have been shown to induce long-term tolerance,…
  • 2016 American Transplant Congress

    Liver Graft Steatosis Associates with an Increase of Circulating Immune Response Chemokines.

    R. Gehrau, V. Mas, A. Sharma, V. Bontha, D. Maluf.

    University of Virginia, Charlottesville.

    Background: Liver graft steatosis, especially macrosteatosis induces severe graft injury post-liver transplantation (LT) by activating cell-mediated immunity and inflammation. This study aimed to determine differential…
  • 2016 American Transplant Congress

    The IFN-Gamma-Inducible Protein (IP-10/CXCL10) Is a Promising Target to Improve Endocrine Function Following Islet Transplantation.

    G. Yoshimatsu,1 M. Kanak,2 P. Balaji S,1 C. Chang,3 C. Darden,3 M. Takita,1 M. Lawrence,1 B. Naziruddin.4

    1Islet Cell Laboratory, Baylor Research Institute, Dallas, TX; 2Transplant Division, Department of Surgery, VCU Medical Center, Richmond, VA; 3Transplant Services, Baylor Simmons Transplant Institute, Dallas, TX.

    A significant mass of transplanted islets is lost very early due to an inflammatory reaction. CXCL10 is a chemokine that is highly expressed in islets…
  • 2016 American Transplant Congress

    Predictors of Early Rejection and Allograft Failure in Pediatric Kidney Transplantation: Impact of Histology and Behavior.

    M. Seifert, M. Yanik, R. Mannon.

    University of Alabama at Birmingham School of Medicine, Birmingham.

    Background: Early inflammatory events that lead to allograft dysfunction are often missed by creatinine-based estimates in children. Surveillance biopsies can detect early allograft dysfunction due…
  • 2016 American Transplant Congress

    The Significance of Microvascular Inflammation in Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation.

    H. Ishihara,1 H. Ishida,1 K. Unagami,2 T. Hirai,1 M. Okumi,1 K. Omoto,1 T. Shimizu,1 K. Tanabe.1

    1Urology, Tokyo Women's Medical University, Tokyo, Japan; 2Nephrology, Tokyo Women's Medical University, Tokyo, Japan.

    Background: In ABO-incompatible (ABOi) transplantation, the criteria for antibody-mediated rejection (AMR) are controversial, as C4d deposition is common in ABOi. This study examined the impact…
  • « Previous Page
  • 1
  • …
  • 31
  • 32
  • 33
  • 34
  • 35
  • …
  • 41
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences